Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.
Saved in:
| Title: | Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer. |
|---|---|
| Authors: | Sipola J; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Center, Tampere University, Tampere, Finland., Munzur AD; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada., Kwan EM; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada.; Department of Medical Oncology, BC Cancer, Vancouver, Canada.; Department of Medicine, School of Clinical Sciences; Monash University, Melbourne, Australia., Seo CCY; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Hauk BJ; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Parekh K; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada., Liao YJR; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada., Bernales CQ; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada., Donnellan G; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada., Bloise I; Instituto Brasileiro de Controle ao Cancer, Sao Paulo, Brazil.; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, Canada., Fung E; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Ng SWS; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada., Wang G; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Vandekerkhove G; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada.; Department of Medical Oncology, BC Cancer, Vancouver, Canada., Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Center, Tampere University, Tampere, Finland., Annala M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Center, Tampere University, Tampere, Finland., Maurice-Dror C; Department of Medical Oncology, BC Cancer, Vancouver, Canada., Chi KN; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada.; Department of Medical Oncology, BC Cancer, Vancouver, Canada., Herberts C; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada., Wyatt AW; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, British Columbia, Canada.; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada., Takeda DY; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. |
| Source: | Cancer research [Cancer Res] 2025 Feb 17; Vol. 85 (4), pp. 791-807. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
